{"AllianceGenome": "6732", "HGNC": "6732", "MIM": "604531", "_id": "9436", "_version": 1, "accession": {"genomic": ["AL136967.5", "CH471081.1", "CP068272.2", "NC_000006.12", "NC_060930.1"], "protein": ["CAB52289.1", "CAB52290.1", "EAX04039.1", "EAX04040.1", "EAX04041.1", "EAX04042.1", "NP_001186438.1", "NP_001186439.1", "NP_004819.2", "O95944.2", "XP_016866989.1", "XP_054212802.1"], "rna": ["AJ010099.1", "AJ010100.1", "NM_001199509.2", "NM_001199510.2", "NM_004828.4", "XM_017011500.2", "XM_054356827.1"], "translation": [{"protein": "XP_054212802.1", "rna": "XM_054356827.1"}, {"protein": "CAB52290.1", "rna": "AJ010100.1"}, {"protein": "NP_001186439.1", "rna": "NM_001199510.2"}, {"protein": "NP_004819.2", "rna": "NM_004828.4"}, {"protein": "XP_016866989.1", "rna": "XM_017011500.2"}, {"protein": "NP_001186438.1", "rna": "NM_001199509.2"}, {"protein": "CAB52289.1", "rna": "AJ010099.1"}]}, "alias": ["CD336", "LY95", "NK-p44", "NKP44", "dJ149M18.1"], "ensembl": {"gene": "ENSG00000096264", "protein": ["ENSP00000362175", "ENSP00000362178", "ENSP00000362181"], "transcript": ["ENST00000373083", "ENST00000373086", "ENST00000373089"], "translation": [{"protein": "ENSP00000362181", "rna": "ENST00000373089"}, {"protein": "ENSP00000362175", "rna": "ENST00000373083"}, {"protein": "ENSP00000362178", "rna": "ENST00000373086"}], "type_of_gene": "protein_coding"}, "entrezgene": "9436", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 9.8570421876, "exp_mis": 91.6187933855, "exp_syn": 42.7583981427, "lof_z": 0.901432167725002, "mis_z": -0.326082303144629, "mu_lof": 7.61239049357e-07, "mu_mis": 8.11132810373e-06, "mu_syn": 3.71222454736e-06, "n_lof": 7.0, "n_mis": 98.0, "n_syn": 58.0, "p_li": 0.000163783304597834, "p_null": 0.318738598549575, "p_rec": 0.681097618145827, "syn_z": -1.44500488039396}, "bp": 831, "cds_end": 41318602, "cds_start": 41303614, "n_exons": 5, "nonpsych": {"exp_lof": 8.82804217057, "exp_mis": 82.8303191923, "exp_syn": 38.606944169, "lof_z": 0.604235124521428, "mis_z": -0.452764162942443, "mu_lof": 7.61239049357e-07, "mu_mis": 8.11132810373e-06, "mu_syn": 3.71222454736e-06, "n_lof": 7.0, "n_mis": 91.0, "n_syn": 54.0, "p_li": 0.00010319488916311, "p_null": 0.449336491317976, "p_rec": 0.550560313792861, "syn_z": -1.55975282989347}, "nontcga": {"exp_lof": 9.05936225933, "exp_mis": 84.2801789404, "exp_syn": 39.3286111106, "lof_z": 1.33042438826116, "mis_z": -0.3646740077863, "mu_lof": 7.61239049357e-07, "mu_mis": 8.11132810373e-06, "mu_syn": 3.71222454736e-06, "n_lof": 5.0, "n_mis": 91.0, "n_syn": 57.0, "p_li": 0.0043742048367556, "p_null": 0.126023883925353, "p_rec": 0.869601911237892, "syn_z": -1.7841801490205}, "transcript": "ENST00000373089.5"}, "exons": [{"cdsend": 41350703, "cdsstart": 41335876, "chr": "6", "position": [[41335607, 41335928], [41336086, 41336428], [41341793, 41341929], [41341999, 41342149], [41342917, 41343024], [41350677, 41350889]], "strand": 1, "transcript": "NM_001199509", "txend": 41350889, "txstart": 41335607}, {"cdsend": 41350703, "cdsstart": 41335876, "chr": "6", "position": [[41335607, 41335928], [41336086, 41336428], [41341793, 41341929], [41342035, 41342149], [41342917, 41343024], [41350677, 41350889]], "strand": 1, "transcript": "NM_001199510", "txend": 41350889, "txstart": 41335607}, {"cdsend": 41350864, "cdsstart": 41335876, "chr": "6", "position": [[41335607, 41335928], [41336086, 41336428], [41341793, 41341929], [41342035, 41342149], [41350677, 41350889]], "strand": 1, "transcript": "NM_004828", "txend": 41350889, "txstart": 41335607}], "exons_hg19": [{"cdsend": 41318441, "cdsstart": 41303614, "chr": "6", "position": [[41303345, 41303666], [41303824, 41304166], [41309531, 41309667], [41309737, 41309887], [41310655, 41310762], [41318415, 41318627]], "strand": 1, "transcript": "NM_001199509", "txend": 41318627, "txstart": 41303345}, {"cdsend": 41318441, "cdsstart": 41303614, "chr": "6", "position": [[41303345, 41303666], [41303824, 41304166], [41309531, 41309667], [41309773, 41309887], [41310655, 41310762], [41318415, 41318627]], "strand": 1, "transcript": "NM_001199510", "txend": 41318627, "txstart": 41303345}, {"cdsend": 41318602, "cdsstart": 41303614, "chr": "6", "position": [[41303345, 41303666], [41303824, 41304166], [41309531, 41309667], [41309773, 41309887], [41318415, 41318627]], "strand": 1, "transcript": "NM_004828", "txend": 41318627, "txstart": 41303345}], "generif": [{"pubmed": 12351833, "text": "crystallization and preliminary crystallographic characterization of the extracellular Ig-like domain of human natural killer cell activating receptor"}, {"pubmed": 12645956, "text": "The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44."}, {"pubmed": 12653925, "text": "homology of the gene on chromosome 6, close to MHC class I loci to the most common bacterium in postdiarrheal Reiter's syndrome may be significan"}, {"pubmed": 12731048, "text": "Selective cross-talk among natural cytotoxicity receptors (NKp46, NKp30 and NKp44) in human natural killer cells."}, {"pubmed": 12791260, "text": "The 2.2 A crystal structure of NKp44 presented here shows that the NKp44 Ig domain forms a saddle-shaped dimer, where a charged surface groove protrudes from the core structure in each subunit."}, {"pubmed": 14707061, "text": "All activating properties and surface expression of NKp44 are mediated through its association with DNAX-activation protein 12 (DAP12) in NK cells, and the cytoplasmic inhibitory domain of NKp44 does not appear to attenuate activating function."}, {"pubmed": 15657183, "text": "NKG2D, NKp30, NKp44, and NKp46 acitvation affected by ligand-negative phenotype in bone marrow-derived progenitor cells, acquisition of cell-surface ligands during myeloid differentiation, defective expression of ligands on malignant transformation"}, {"pubmed": 15728472, "text": "NKp44 is not only a triggering molecule essential for antitumor activity but is also a surface receptor involved in natural killer cell suicide."}, {"pubmed": 15941912, "text": "NKp44 is present on a subset of natural interferon-producing cells (IPCs) in tonsils. Crosslinking of NKp44 does not trigger IPC-mediated cytotoxicity but, paradoxically, inhibits IFN-alpha production by IPCs in response to CpG oligonucleotides."}, {"pubmed": 16210654, "text": "Freshly isolated natural killer (NK) cells are NKp44 negative; lysis of porcine endothelial cells mediated by activated human NK cells depends on both NKp44 and NKG2D"}, {"pubmed": 17536787, "text": "Characterization of the recognition of tumor cells by NKP44 is reported."}, {"pubmed": 18023431, "text": "Determined expressions of NKp44 in decidual natural killer cells in patients having spontaneous abortions."}, {"pubmed": 18077718, "text": "Recombinant NKp44 recognizes H5-expressing cells and specifically interacts with soluble H5 hemagglutinin."}, {"pubmed": 18092004, "text": "Expression of NKp30 and NKp44 ligands was variable and did not correlate with the origin of the cell line. Expression of NKp30 and NKp44 ligand correlated with NKp30 and NKp44-mediated NK cell lysis of tumor cells, respectively"}, {"pubmed": 19635919, "text": "Natural killer (NK)-activating receptor NKp44 is involved in virally mediated NK activation through direct interaction with the flavivirus envelope protein."}, {"pubmed": 20237496, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20638936, "text": "The balance of NKp44(+)/NKp46(+) NK cells is disrupted in intestinal mucosa of patients with Crohn's disease."}, {"pubmed": 21151495, "text": "Data show that pDCs isolated from peripheral blood of systemic lupus erithematosus (SLE) patients express lower levels of LAIR-1 while displaying slight but consistent expression of NKp44."}, {"pubmed": 22021614, "text": "We demonstrate that PCNA promotes cancer survival by immune evasion through inhibition of NKp44-mediated NK cell attack."}, {"pubmed": 22044312, "text": "a precise analysis of clinical data showed a correlation between decreased NCR expression and poor prognosis factors such as low haemoglobin level, high (>30x10(9) per litre) lymphocyte count or elevated C-reactive protein"}, {"pubmed": 22674989, "text": "These data show that the Kaposi's sarcoma-associated herpesvirus ORF54 product downregulates the NKp44 ligand and that the NKp44-NKp44 ligand signaling pathway contributes to antiviral immunity."}, {"pubmed": 23345327, "text": "Natural cytotoxicity receptors play a major role in the recognition by NK cells of cancer stem cells targets."}, {"pubmed": 23527218, "text": "Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44."}, {"pubmed": 23578092, "text": "While interaction of TLR2 with mycobacterial cell wall promotes activation of resting NK cells and IFN-gamma production, NKp44 interaction with its putative ligands could play a secondary role in maintaining cell activation"}, {"pubmed": 23791642, "text": "triggering in RORgammat-positive innate lymphoid cells selectively activates a proinflammatory program"}, {"pubmed": 23818644, "text": "Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation."}, {"pubmed": 23958951, "text": "MLL5 is a cellular ligand for the natural cytotoxicity receptor NKp44."}, {"pubmed": 24044960, "text": "Expression of NKp44 ligand by normal articular chondrocytes is not involved in their killing by unstimulated NK cells; however, it is responsible for anti-chondrocyte cytotoxicity mediated by long-term activated NK cells."}, {"pubmed": 24154937, "text": "demonstrated that the mitogen and iK562 exposure to peripheral blood mononuclear cells can significantly improve NK activity which is co-related to the higher expression of NKp44 and NKG2D"}, {"pubmed": 24352038, "text": "NKp44+ ILC3 are expressed in human skin and blood and may have a role in psoriasis pathogenesis"}, {"pubmed": 24658504, "text": "NCR(+) ILC3 from skin and blood of psoriasis patients produced IL-22, which is regarded as a key driver of epidermal thickening, suggesting that NCR(+) ILC3 may participate in psoriasis pathology."}, {"pubmed": 24673109, "text": "Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts."}, {"pubmed": 24824867, "text": "On CD56(+) CD3(-) cells, NKp44 and NKp46 expressions were high in the acute hepatitis E patients, whereas NKp30, NKp44, NKp46 and NKG2D were high in the recovered individuals."}, {"pubmed": 27102296, "text": "NKp44-1 expression was significantly associated with poor survival of AML patients. Moreover, activation of PBMC from healthy controls showed co-dominant expression of NKp44-1 and NKp44-3, while primary NK clones show more diverse NKp44 splice variant profiles."}, {"pubmed": 27765926, "text": "NKp44 and NKp30 splice variants profiles are tissue/condition specific and demonstrate similarity between placenta and cancerous tissues."}, {"pubmed": 29247708, "text": "Increased expression of p44 natural killer cell receptor (NKp44 ) was associated earlier stages of diffuse large B-cell lymphoma (DLBCL)."}, {"pubmed": 29447242, "text": "Study identified a novel ligand for NKp44 on astrocytes. Expression of this novel ligand decreased with increasing HIV-3S peptide concentration and blocking this novel ligand decreased NK cell killing. NK cell killing of astrocytes was decreased when astrocytes were incubated with HIV-3S peptide. NKp44 has a protective effect on astrocytes from NK cell mediated killing during HIV infection and impact astrocyte's role."}, {"pubmed": 29683419, "text": "The regulation of T cell proliferation during HPIV3 infection is mediated via NK receptors NKp44 and NKp46 and involves the surface glycoprotein haemagglutinin-neuraminidase but not the fusion protein of the virus."}, {"pubmed": 29875773, "text": "We therefore identified the NKp44 binding site to PCNA and further developed an NKp44-peptide-based agent that can inhibit tumor growth through interfering with the function of intracellular PCNA in the tumor cell."}, {"pubmed": 31024551, "text": "NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans."}, {"pubmed": 31134055, "text": "The Natural Cytotoxicity Receptors in Health and Disease."}, {"pubmed": 31989589, "text": "Low-dose IL-2 induces CD56(bright) NK regulation of T cells via NKp44 and NKp46."}, {"pubmed": 32229590, "text": "Human NKp44(+) Group 3 Innate Lymphoid Cells Associate with Tumor-Associated Tertiary Lymphoid Structures in Colorectal Cancer."}, {"pubmed": 38615318, "text": "NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells."}], "genomic_pos": {"chr": "6", "end": 41350889, "ensemblgene": "ENSG00000096264", "start": 41335608, "strand": 1}, "genomic_pos_hg19": {"chr": "6", "end": 41318625, "start": 41303393, "strand": 1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0006968", "pubmed": 10049942, "qualifier": "involved_in", "term": "cellular defense response"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007165", "pubmed": 10049942, "qualifier": "involved_in", "term": "signal transduction"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0009986", "qualifier": "is_active_in", "term": "cell surface"}], "MF": [{"category": "MF", "evidence": "TAS", "id": "GO:0004888", "pubmed": 10049942, "qualifier": "enables", "term": "transmembrane signaling receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [10049942, 14707061, 22021614, 23958951], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0038023", "qualifier": "enables", "term": "signaling receptor activity"}]}, "homologene": {"genes": [[9544, 693869], [9598, 472004], [9606, 9436], [9615, 609023]], "id": 130365}, "interpro": [{"desc": "Immunoglobulin subtype", "id": "IPR003599", "short_desc": "Ig_sub"}, {"desc": "Immunoglobulin-like domain", "id": "IPR007110", "short_desc": "Ig-like_dom"}, {"desc": "Immunoglobulin V-set domain", "id": "IPR013106", "short_desc": "Ig_V-set"}, {"desc": "Immunoglobulin-like fold", "id": "IPR013783", "short_desc": "Ig-like_fold"}, {"desc": "Immunoglobulin-like domain superfamily", "id": "IPR036179", "short_desc": "Ig-like_dom_sf"}], "ipi": ["IPI00034050", "IPI00414863", "IPI00420072"], "map_location": "6p21.1", "name": "natural cytotoxicity triggering receptor 2", "other_names": ["NK cell activating receptor (NKp44)", "NK cell-activating receptor", "lymphocyte antigen 95 (activating NK-receptor; NK-p44)", "lymphocyte antigen 95 homolog (activating NK-receptor; NK-p44)", "natural cytotoxicity triggering receptor 2", "natural killer cell p44-related protein"], "pantherdb": {"HGNC": "6732", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"Ensembl": "ENSGALG00000023780", "ortholog_type": "O", "panther_family": "PTHR16423", "taxid": 9031, "uniprot_kb": "H9L1E0"}, {"Ensembl": "ENSGALG00000003361", "ortholog_type": "O", "panther_family": "PTHR16423", "taxid": 9031, "uniprot_kb": "F7B5T9"}, {"Ensembl": "ENSGALG00000023781", "ortholog_type": "O", "panther_family": "PTHR16423", "taxid": 9031, "uniprot_kb": "A0A1D5PLP7"}], "uniprot_kb": "O95944"}, "pathway": {"kegg": {"id": "hsa04650", "name": "Natural killer cell mediated cytotoxicity - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1280218", "name": "Adaptive Immune System"}, {"id": "R-HSA-168249", "name": "Innate Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-198933", "name": "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"}, {"id": "R-HSA-2172127", "name": "DAP12 interactions"}]}, "pdb": "1HKF", "pfam": "PF07686", "pharmgkb": "PA30496", "pharos": {"target_id": 664, "tdl": "Tbio"}, "prosite": "PS50835", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF260131", "relationship": "is"}, {"id": "GNF260132", "relationship": "is"}, {"id": "GNF260133", "relationship": "is"}, {"id": "GNF260134", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF098953", "relationship": "is"}, {"id": "GNF138608", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000006.12", "NC_060930.1"], "protein": ["NP_001186438.1", "NP_001186439.1", "NP_004819.2", "XP_016866989.1", "XP_054212802.1"], "rna": ["NM_001199509.2", "NM_001199510.2", "NM_004828.4", "XM_017011500.2", "XM_054356827.1"], "translation": [{"protein": "NP_001186439.1", "rna": "NM_001199510.2"}, {"protein": "NP_004819.2", "rna": "NM_004828.4"}, {"protein": "XP_016866989.1", "rna": "XM_017011500.2"}, {"protein": "NP_001186438.1", "rna": "NM_001199509.2"}, {"protein": "XP_054212802.1", "rna": "XM_054356827.1"}]}, "reporter": {"HG-U133_Plus_2": ["217045_x_at", "217493_x_at", "221075_s_at"], "HG-U95Av2": "34064_s_at", "HTA-2_0": "TC06000567.hg.1", "HuEx-1_0": "2906749", "HuGene-1_1": "8119435", "HuGene-2_1": "17008463"}, "summary": "Predicted to enable signaling receptor activity. Predicted to be involved in cellular defense response and signal transduction. Predicted to be located in plasma membrane. Predicted to be integral component of plasma membrane. Predicted to be active in cell surface. [provided by Alliance of Genome Resources, Apr 2022]", "symbol": "NCR2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1416942"}, "unigene": "Hs.194721", "uniprot": {"Swiss-Prot": "O95944"}, "wikipedia": {"url_stub": "NCR2"}}